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1. Introduction
1.1. Etiology of pancreatitis and risk factors
Acute pancreatitis (AP) is one of the most common gastrointestinal diseases requiring
hospitalization worldwide, with a rising incidence ranging from 13 to 45 per 100,000 persons/
year. The burden of this disease on patients and society is expected to increase even more.
Chronic pancreatitis (CP) is a progressive fibro-inflammatory disorder which eventually
culminates in permanent impairment of the exocrine and/or endocrine pancreatic function.
Although the incidence and prevalence of CP is lower than the reported for AP, this disease
significantly reduces patients’ quality of life. The annual incidence of CP in industrialized
countries has been estimated at 5-12 per 100,000, with a prevalence of about 50 per 100,000
persons [1].
Many conditions are known to potentially cause pancreatitis with varying degrees of certainty,
and although some variations have been described between countries, most of cases are
attributed to biliary stones or sludge, followed by alcohol abuse. Advances in imaging,
molecular biology and genetics have broadened the list of possible etiologies, and the number
of presumed idiopathic cases (10-15%) will decrease as our understanding of the disease
improves [1,2].
The etiology of pancreatitis should be determined on admission or in the early course of the
disease, as this allows the clinician to choose the most appropriate management strategies and
therapy in acute phase, and prevent recurrence. A detailed personal history (including data
such as previous acute pancreatitis or gallstone disease, alcohol abuse, drug intake, metabolic
syndromes, trauma or recent invasive procedures, concomitant autoimmune diseases) and
family history of pancreatic disorders can provide guidance for a first etiological approach.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Physical examination, biochemical tests (liver enzymes, calcium, triglycerides) and the
appropriate performance of imaging studies will help to make a differential diagnosis among
biliary, alcoholic and other causes of pancreatitis.
In this chapter, the aim will be to conduct a comprehensive and updated review of the possible
causes of pancreatitis (Table 1) and associated risk factors.
2. Risk factors of pancreatitis
2.1. Age and sex
Although the incidence of AP do not differ according to sex, CP is more common among men.
The risk of AP increases with age, whereas CP mainly affects middle-age individuals. Besides,
age and sex distribution is different by etiology. Usually, alcohol-related pancreatitis is more
common in middle-aged men. By contrast, pancreatitis in women is more frequent related to
gallstones, instrumental procedures, autoimmune diseases or to be idiopathic. Geographic
variations observed in age and sex distribution can be partly explained by differences in
etiology [1,3].
2.2. Race
The risk of pancreatitis is 2 to 3-fold higher among the black population than the whites. Little
is known about the possible reasons of this racial disparity and further studies are needed to
determine whether these observed differences may be related to dietary, genetic or other
factors [1,4].
2.3. Lifestyle factors
2.3.1. Diet
The role of dietary factors in the etiology of pancreatitis is unclear. The consumption of high
glycemic foods has been associated with an increased risk of non-gallstone-related acute
pancreatitis. By contrast, it has been suggested that vegetables and fruit consumption are
associated with reduced risk for pancreatic diseases [5,6].
It also should be noted that celiac disease increases the risk of pancreatitis by approximately
3-fold. Diffuse inflammation of the duodenum and papillary stenosis may be the mechanisms
involved [7].
Dietary pattern is an area for future research, with other new issues to analyze as the role of
the microbiota in pancreatic diseases [8].
2.3.2. Obesity
It has been found that abdominal adiposity increases the risk and severity of AP. The over‐
weight has similar effect for gallstone and non-gallstone-related inflammation [5,9].
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2.3.3. Diabetes
Some studies found that type 2 diabetes mellitus increases the risk of AP by 1.5 to 3-fold,
particularly in younger diabetic patients [10]. This risk may be attributed to diabetes itself, but
also to other associated factors with this metabolic disorder (gallstones, hypertriglyceridemia)
or the use of antidiabetic drugs such as dipeptidyl peptidase 4 inhibitors (sitagliptin) or
glucagon-like peptide 1 agonist (exenatide) [11].
3. Etiology of pancreatitis
3.1. Obstructive disorders
Mechanical ampullary obstruction can be induced mainly by gallstone, but also for a wide
variety of other disorders [1,2].
3.1.1. Gallstones
Gallstones (including microlithiasis) are the most common etiology of AP, accounting for at
least 35-45% of cases. However, only 3 to 7% of patients with gallstones develop pancreatitis.
The risk increases with the age, female gender and small gallstones. The rising incidence of
obesity is likely to contribute to AP by promoting gallstone formation.
Proposed mechanisms in the pathogenesis of this disorder include reflux of bile into the
pancreatic duct due to transient ampullary obstruction and/or secondary to edema resulting
from the passage of stones. Both events may lead to increase pressure in the pancreatic duct,
resulting in injury of the gland with release of pancreatic enzymes causing autodigestion and
triggering AP [12].
Biliary sludge is a viscous suspension in gallbladder bile that may contain small (< 5mm) stones
(i.e., microlithiasis). Its formation has been associated with mechanical or functional conditions
that promote bile stasis, such as distal bile duct obstruction, prolonged fasting, total parenteral
nutrition or use of ceftriaxone [13]. It is commonly found up to 20-40% of patients initially
diagnosed with idiopathic pancreatitis, and in the absence of any other etiology this could be
considered as probable cause of the disease.
Gallstones are not recognized as etiology of CP. However, prolonged ductal obstruction may
lead to development of CP.
3.1.2. Pancreatic/ampullary obstruction
Pancreatic  and  periampullary  tumors  can  cause  pancreatitis.  The  intraductal  papillary
mucinous neoplasm is  the most commonly involved,  due to obstruction of  main and/or
side  branches  of  pancreatic  duct  by  the  tumor  itself  and/or  by  mucus  secretion  [14].
Pancreatic  adenocarcinoma  can  also  present  as  pancreatitis,  and  the  acute  attacks  may
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precede the diagnosis of overt malignancy in the gland by several months [15]. It has been
estimated that  approximately  5-14% of  patients  with benign or  malignant  pancreatobili‐
ary tumors are initially diagnosed as idiopathic AP [16]. Unexplained recurrent pancreati‐
tis from the middle age should raise the suspicion of underlying tumor, especially in patients
with worrisome associated symptoms (weight loss, new-onset diabetes).
OBSTRUCTIVE
• Gallstones, microlithiasis, “biliary sludge”
• Benign and malignant strictures, ampullary or pancreatic tumors, mucin (intraductal papillary mucinous neoplasms)
• Anatomic variants: Pancreas divisum, annular pancreas, choledochal cyst, choledochocele, duodenal duplication,
duodenal diverticula
• Sphincter of Oddi dysfunction
• Parasites (Ascaris, Anisakis)
TOXICS
• Alcohol, Tobacco
• Organophosphorous insecticides
• Venoms (Scorpion, spider)
• Estricnine
• Heroin, cocaine
• Drugs: Pentamidine, Thiazide, Furosemide, Azathioprine, 6-Mercaptopurine, Sulindac, Salicylates, L-asparaginase,
Valproic acid, Calcium, Estrogen, Tamoxifen, Sulfonamide, Tetracycline.
METABOLIC. Hypertriglyceridemia, Hypercalcemia
HEREDITARY / GENETIC
• Hereditary pancreatitis
• Cystic fibrosis
TRAUMA/IATROGENIC
• Post-endoscopic retrograde cholangiopancreatography
• Transparietohepatic cholangiography
• Pancreas biopsy / Fine-needle aspiration
• Transcatheter arterial embolization for hepatocellular carcinoma
• Posoperative
INFECTIONS
• Viruses: Mumps, Coxsackievirus, Cytomegalovirus, Varicella-zoster, Herpes simplex, EpsteinBarr, Human
immunodeficiency virus, Hepatitis A, B and C
• Bacteria: Mycoplasma, Mycobacterium tuberculosis, Leptospira, Legionella, Salmonella Typhi
• Fungi: Aspergillus
• Parasites: Toxoplasma, Cryptosporidium, Clonorchis sinensis
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VASCULAR DISEASE
• Hypotension/Ischemia
• Vasculitis
• Atheromatosis, emboli to pancreatic vessels
• Hypothermia
• Haemolysis
AUTOIMMUNE
MISCELLANEOUS. Celiac disease, Crohn´s disease, Severe Burns, Tropical pancreatitis, Posterior Penetrating Duodenal
Ulcer
IDIOPHATIC
Table 1. Etiological factors associated with acute pancreatitis.
3.1.3. Anatomic/Functional abnormalities
Other conditions that have been associated with obstructive pancreatitis include anatomic
variants and physiologic anomalies of the pancreatic drainage that occur in 10-15 % of the
population, including pancreas divisum and sphincter of Oddi dysfunction (SOD).
3.1.4. Pancreas divisum
It is the most common congenital malformation of the pancreas. It is due to the fusion failure
between the dorsal and ventral pancreas, resulting in separate pancreatic ductal systems. It is
found in approximately 7% of autopsy series. The implication of this anatomic variant as a
potential cause of AP remains controversial. The proposed pathogenic mechanism is the
relative obstruction to pancreatic juice flow through the minor papilla, leading to increased
intraductal pressure. However, since the rate of AP in patients with pancreas divisum is similar
to the general population, it has been suggested that the involvement of other factors is
required to the development of the disease. In this regard, the prevalence of this malformation
in patients with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR)
was found to be higher than in patients with idiopathic or alcohol-related AP, or control
subjects [13,17].
3.1.5. Sphinter of Oddi dysfunction
SOD is also a controversial cause of AP (Table 2). The involved mechanism is associated with
spasm or stenosis of the sphincter muscle controlling the bile and pancreatic flow into the
duodenum. Pancreatic-type SOD ranges from patients with pancreatic-type pain, raised serum
amylase or lipase and pancreatic duct dilatation (Type I), to those with pancreatic-type pain
and no other abnormalities (Type III). The importance of this condition as cause of recurrent
AP is not clearly established, although it has been considered to cause up to one third of all
cases of idiopathic pancreatitis [16].
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Biliary type Pancreatic type
Type I
• Biliary-type pain
• And all of the following:
- Abnormal aminotransferases or alkaline phosphatase (>2
times normal on at least 2 ocassions)
- Dilated bile duct (>8 mm)
Type I
• Pancreatic-type pain
• And all of the following:
- Amylase/lipase (>1.5 times normal)
- Pancreatic duct >6 mm in head or >5mm in body
- Delayed drainage of contrast after ERCP
(>9 minutes)
Type II
• Biliary-type pain
• And one of the following:
- Abnormal aminotransferases or alkaline phosphatase (>2
times normal on at least 2 ocassions)
- Dilated bile duct (>8 mm)
Type II
• Pancreatic-type pain
• And one or two of the following:
- Amylase/lipase (>1.5 times normal)
- Pancreatic duct >6 mm in head or >5mm in body
- Delayed drainage of contrast after ERCP
(>9 minutes)
Type III
Biliary-type pain only
Type III
Pancreatic-type pain only
Table 2. Sphincter of Oddi dysfunction. Revised Classification Milwaukee. The Rome III Consensus Statement.
3.2. Toxics
3.2.1. Alcohol
The prevalence of AP is approximately 4-fold higher among subjects who are alcohol con‐
sumers compared to nondrinkers. However, the absolute risk of developing alcohol-related
pancreatitis is lower than that for chronic alcohol liver diseases and ranges from 5% to 10% for
large consumers [18,19]. Alcohol intake is the single most common cause of CP, and the second
after gallstones for AP being responsible for about 30-35% of cases of acute attacks.
The risk of acute alcohol-induced pancreatitis increases in a dose-dependent manner, with a
threshold for CP of approximately 4-5 drinks/day. Chronic alcoholic patients eventually
develop CP after 10 to 20 years of continuous alcohol abuse. The contribution of the beverage
type to this risk requires further studies [19,20].
Although the exact mechanism of pancreatic injury remains unclear, alcohol may act directly
on the acinar cells as a toxic by promoting the synthesis of enzymes, activation of pancreatic
proteases, changes in cellular lipid metabolism, induction of oxidative stress, activation of
stellate cells and/or by increasing the sensitivity of the gland to other genetic and environ‐
mental factors.
Two pathogenic theories have been described. In one, alcohol-related injury is the result of
perturbations in exocrine function leading to an increase of the lithogenicity of pancreatic
juice and the formation of  protein plugs and stones.  Atrophy and fibrosis  develop as  a
result  of  the  obstructive  process.  The  other  theory  proposed  a  stepwise  progression  to
fibrosis after recurrent attacks of AP. Inflammation and necrosis from the initial episodes
Acute and Chronic Pancreatitis8
of AP lead to areas of scarring, ductal obstruction, stasis and subsequent stone formation.
However, given the low rate of pancreatitis among heavy drinkers, it has been suggested
that other genetic and environmental cofactors would be required for the development of
alcoholic pancreatitis [19,21].
3.2.2. Smoking
Tobacco and alcohol are cofactors that increase the risk of pancreatitis. Furthermore, both
habits often coexist and are enhanced in a dose-dependent manner. However, large studies
have suggested that smoking alone is an independent risk factor for both AP and CP [22,23].
It has been reported that smoking increases by approximately 2-fold the risk of non-gallstone-
related AP, but not for gallstone-related pancreatitis. This risk was higher in patients who
consumed alcohol, current smokers and those with more than 20 packs-years of smoking,
particularly if they met the three characteristics (relative risk, 4.12) [24].
Regarding CP, smoking alone has been attributed 25% of the risk for this disease. It has been
calculated a risk more than 2-fold among subjects who smoked less than one pack/day, and
more than 3-fold for those with higher consumption [25].
At this time, there is very little information about the pathogenesis of smoking-induced
pancreatitis compared with those of other causes. Data from animal models suggest several
potential mechanisms such as altered gene expression in the exocrine pancreas and activation
of pancreatic enzymes with acinar cell damage. Nicotine has also been shown to modulate the
oxidative stress and lipid peroxidation and these processes might be involved in the patho‐
physiology of acute and chronic pancreatitis. As is becoming evident with respect to alcohol,
there may be other environmental and/or genetic factors that may promote pancreatic injury
with smoking [26].
3.2.3. Drugs
AP due to drugs is a rare event (2%). Over one hundred of different medications have been
related in the development of the disease by several mechanims. These include immunologic
reactions (azathioprine, 6-mercaptopurine, aminosalicylates, sulfonamides), a direct toxic
effect (diuretics, sulfonamides), accumulation of toxic metabolites (valproic acid, didanosine,
pentamidine, tetracycline), ischemia (diuretics, azathioprine), intravascular thrombosis
(estrogen), and increased viscosity of pancreatic juice (diuretics and steroids). No medications
are known to cause CP.
Drug-induced pancreatitis has been classified (I-IV) (Table 3) according to the number of
registered cases, latency period and reaction with rechallenge: Class Ia drugs (at least 1 case
report with positive rechallenge, excluding all other causes, such as alcohol, hypertriglyceri‐
demia, gallstones, and other drugs), Class Ib drugs (at least 1 case report with positive
rechallenge; however, other causes, such as alcohol, hypertriglyceridemia, gallstones, and
other drugs were not ruled out), Class II drugs (at least 4 cases in the literature and consistent
latency in ≥75% of cases), Class III drugs (at least 2 cases in the literature with no consistent
latency among cases and no rechallenge) and Class IV drugs (Not fitting into the earlier-
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described classes, single case report published in medical literature, without rechallenge).
Classes I and II have the greatest potential for causing AP. The time interval between beginning
of the drug and the development of the disease is highly variable, depending on the substance
involved and its pathogenic mechanism. Therefore, a high index of suspicion and a detailed
drug history are essential for making the diagnosis [27,28].
3.2.4. Others toxics
Organophosphate pesticides, arachnids and reptiles venoms have been described to cause AP
by cholinergic stimulation [2]. Cocaine consumption may cause pancreatitis by vasoconstrictor
and ischemic effects [29].
Class IA
α-methyldopa
Azodisalicylate
Bezafibrate
Cannabis
Carbimazole
Codeine
Cytosine
Arabinoside
Dapsone
Enalapril
Furosemide
Isoniazid
Mesalamine
Metronidazole
Pentamidine
Pravastatin
Procainamide
Pyritonol
Simvastatin
Stibogluconate
Sulfamethoxazole
Sulindac
Tetracycline
Valproic acid
Class IB
All-trans-retinoic acid
Amiodarone
Azathioprine
Clomiphene
Dexamethasone
Ifosfamida
Lamivudine
Losartan
Lynesterol/
Metho-xyethinylestradiol
6- Mercaptopurine
Meglumine
Methimazole
Nelfinavir
Norethindronate/
mestranol
Omeprazole
Premarin
Sulfamethazole
Trimethoprim-
sulfamethazole
Class II
Acetaminophen
Chlorthiazide
Clozapine
Didanosine
Erythromycin
Estrogen
L-asparaginase
Pegasparagase
Propofol
Tamoxifen
Class III
Aledronate
Atorvastatin
Carbamazepine
Captopril
Ceftriaxone
Chlorothalidone
Cimetidine
Clarithromycin
Cyclosporin
Gold
Hydrochlorothiazide
Indomethacin
Interferon/ribavirin
Irbesartan
Isotretinoin
Ketorolac
Lisinopril
Metalozone
Metformin
Minocycline
Mirtazapine
Naproxen
Paclitaxel
Prednisone
Prednisolone
Class IV
Adrenocorticotrophic hormone
Ampicillin
Cisplatin
Colchicine
Diclofenac
Difenoxylate
Fluvastatin
Gemfibrozil
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Bendroflumethiazide
Benzapril
Betamethazone
Capecytabine
Cyclophosphamide
Cyproheptidine
Danazol
Diazoxide
Doxorubicin
Ethacrinic acid
Famciclovir
Finasteride
5-fluorouracil
Interleukin-2
Ketoprofen
Lovastatin
Mefanamic acid
Nitrofurantoin
Data modified from Badalov N et al [28].
Table 3. Summary of the medications associated with pancreatitis based on Drug Class.
3.3. Metabolic disorders
3.3.1. Hypertriglyceridemia
This type of hyperlipidemia induces AP in about 1-4% of cases, and this is an uncommon
etiology of CP. The disease typically develops in patients with a history of familiar hyperlipi‐
demia and/or an associated secondary factor as uncontrolled diabetes, alcohol consumption,
hypothyroidism, nephrotic syndrome, drug intake or pregnancy. The risk is particularly
increased in patients with AP not due to alcoholic or obstructive causes and with high serum
triglyceride concentrations above 1000 mg/dL. Mild-to-moderate hyperlipidemia is often
secondary to alcoholic AP, and should not be confused with marked hypertriglyceridemia
causing AP [2].
The mechanism of hypertriglyceridemia induced pancreatitis is unclear though some authors
suggest stimulation of amylase release, cell damage from free fatty acids and chylomicrons in
acinar cells, and sluggish flow in the capillaries resulting in ischemic injury [13].
3.3.2. Hypercalcemia
This is a rare cause of AP and almost always happens as result of concomitant hyperparathyr‐
oidism. Pancreatitis has been reported to be related to endogenous hypercalcemia by disse‐
minated carcinoma and after iatrogenic effect, for example with total parenteral nutrition or
vitamin D poisoning. Proposed mechanisms include deposition of calcium in pancreatic duct
and calcium activation of trypsinogen within the pancreatic parenchyma. Because the inci‐
dence of pancreatitis is low in patients with chronic hypercalcemia, additional factors are
probable necessary to induce acute episodes [13,30].
3.4. Hereditary/genetic pancreatitis
In pancreatitis, alterations in several genes have so far been described [31].
Hereditary pancreatitis is an autosomal dominant disorder with high penetrance rates up to
80%. This disorder is associated with mutations in the trypsinogen gen PRSS1 that promotes
the premature conversion of trypsinogen to active trypsin, resulting in pancreatic autodiges‐
tion. This genetic syndrome is characterized by a strong family history of pancreatic disease,
and most patients develop recurrent pancreatitis from childhood, with progressive evolution
to CP and a significant increase in risk of pancreatic cancer.
Etiology of Pancreatitis and Risk Factors
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Severe homozygote mutations in CFTR gene cause cystic fibrosis. Patients who are compound
heterozygotes for mild mutations have 40 to 80-fold increased risk of developing CP compared
with the general population, without presenting other manifestations of cystic fibrosis and
with a normal sweat chloride test.
Mutations in the serine protease inhibitor kazal type 1 gene (SPINK1) and chymotrypsin C
(CTRC) are associated with acute and chronic pancreatitis. Patients who have severe mutations
typically develop CP in childhood. Other mutations predispose to the development, but do
not necessarily cause pancreatitis.
3.5. Trauma and medical procedures
3.5.1. Blunt or penetrating trauma
Both types of injuries may cause pancreatitis in about 0.2% and 1% cases respectively, ranging
from a mild contusion to a severe damage [2]. These conditions can lead to acute duct rupture
and pancreatic ascites. The low rates of AP after trauma result from the retroperitoneal location
of the gland. The injury healing may result in a narrowing of the main pancreatic duct, causing
obstructive pancreatitis in the gland downstream from the stricture.
Rarely a posterior duodenal ulcer can penetrate into the pancreas and thereby induce AP. This
complication may present as gastrointestinal bleeding.
3.5.2. Post-ERCP
The result of instrumentation of the gland as in endoscopic retrograde cholangiopancreatog‐
raphy (ERCP) can result in post-ERCP pancreatitis. This injury occurs in 3-5% of unselected
patients and although the episodes are usually mild, up to 11% of cases the disease is severe.
The risk of post-ERCP pancreatitis may be increased up to 25% in those with suspected SOD
or in those with a prior history of post-ERCP pancreatitis. Other risk factors for the develop‐
ment of this complication include young age, female sex, repeated attempts of papilla cannu‐
lation and poor emptying of pancreatic duct after contrast injection. Proposed underlying
mechanisms that may be involved in the pathogenesis of post-ERCP pancreatitis are mechanic
damage from manipulation, and/or chemical, hydrostatic or thermal injury around the
papillary orifice or over pancreatic duct [32,33].
3.5.3. Postoperative pancreatitis
This complication can occur after abdominal or thoracic surgery. It has been described in about
0.4-7.6% after cardiopulmonary bypass and 6% after liver transplantation. Significant risks for
postoperative pancreatitis include renal insufficiency, hypotension, and infections. Intraoper‐
ative or postoperative medications may also cause pancreatitis [34,35].
Other procedures have also been described as cause of iatrogenic pancreatitis (transparieto‐
hepatic cholangiography, pancreatic biopsy/fine-needle aspiration). Pancreatitis after trans‐
arterial embolization for the treatment of hepatocellular carcinoma results from a retrograde
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injection of the chemotherapeutic or embolic agents into pancreatic arteries, giving rise to
ischemic pancreatitis [36].
3.6. Infectious diseaSES
Many infectious agents are associated with AP (Table 1), but no microorganism has ever been
identified within the pancreas. Mumps and Coxsackie B virus are the most common causes of
infectious pancreatitis. Other viruses (Cytomegalovirus, Herpes simplex, Varicella-zoster,
Hepatitis B), bacteria (Salmonella typhi, Leptospira, Legionella), fungi (Aspergillus) and parasites
(Toxoplasma, Cryptosporidium) have all been associated with AP. Clonorchis sinensis and Ascaris
cause pancreatitis by invading and blocking the pancreatic duct [2,37].
AP may be caused by HIV infection or secondary to anti-retroviral treatment. In acquired
immunodeficiency syndrome (AIDS), other infectious agents may cause pancreatitis including
Cytomegalovirus, Candida, Cryptosporidium neoformans, Toxoplasma gondii, Pneumocystis
carinii and Mycobacterium avium complex [38].
3.7. Vascular diseases
Pancreatic ischemia has been reported in the following circumstances: hypotension, hemor‐
rhagic shock, vasculitis (systemic lupus erythematosus and polyarteritis nodosa), atheroemb‐
olism, hypothermia, haemolysis and emboli to pancreatic vessels. It has been described
episodes of AP in long-distance runners, on an ischemic basis [2].
3.8. Autoimmune pancreatitis
Less than 5% of patients evaluated in a tertiary center with pancreatitis on admission, were
diagnosed as autoimmune pancreatitis (AIP). This disease may present in a variety of ways
and among patients with this disease, only 10% to 25% have features of AP o CP at the time
of presentation.
AIP has distinct clinical and histological features. Two subtypes are known, the type 1
(lymphoplasmacytic sclerosing pancreatitis) is a multi-organ disease associated with IgG4, and
type 2 (idiopathic duct centric pancreatitis) appears to be a pancreas-specific disorder with
characteristic granulocyte-epithelial lesions [39]. Immunologic abnormalities including
hypergammaglobulinemia, elevated serum IgG4 levels and the presence of autoantibodies
against lactoferrin and carbonic anhydrase are important serological markers of the type 1 AIP.
Because the diagnosis can be elusive, several criteria have proposed to diagnose AIP. The most
widely used in the United States are the HISORT criteria (histology, imaging, serology, other
organ involvement and response to therapy) [40]. Abnormal imaging can be observed in
computed tomography, magnetic resonance imaging or endoscopic ultrasound as multifocal
or diffuse pancreatic-ductal narrowing, and abnormal enhancement or enlargement of the
pancreas. Histologic confirmation is desirable and can be obtained by endoscopic ultrasound-
guided biopsy of the pancreas. Ampullary biopsy with IgG4 immunostaining may be a safer
alternative with a specificity approaching 100% but a sensitivity of about 50% [41]. AIP clearly
responds to steroid therapy although spontaneous resolution without treatment has also been
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described; however relapses are relatively common. In some cases, other immunosuppressive
agents are necessary.
3.9. Miscellaneous conditions
3.9.1. Celiac disease
There is an increased risk of developing pancreatitis in patients with celiac disease and between
10% and 20% of newly diagnosed patients may develop pancreatic insufficiency. It has been
described that celiac disease is associated with a 3-fold increased risk of development any form
of pancreatitis and even higher for CP (HR: 19.8). This increased risk was only found among
celiac individuals diagnosed in adulthood, and was generally noted in the first year of
diagnosis especially for CP and enzyme supplementation, but remained even 5 years after [7].
Several factors might contribute to the association between celiac disease and pancreatitis [13].
The earliest proposed mechanism was malnutrition, which impairs the secretion of pancreatic
enzymes and influences the composition of the bile inducing microlithiasis, thus predisposing
to development of pancreatitis. Malnutrition has also been described to be associated with
increased levels of pro-inflammatory cytokines as well as pancreatic acinar cell damage, ductal
disruption and other structural changes, such as acinar atrophy. Other proposed mechanisms
include altered levels of autoregulatory enteric hormones (cholecystokinin) and papillary
stenosis resulting from localized duodenal inflammation. Another potential explanation
involves immunopathogenetic mechanisms, by T helper cell class 1 (TH1) cytokine up-
regulation in celiac disease through polymorphisms in tumor necrosis factor-α, a TH1
proinflammatory cytokine, which plays an important role in the pathogenesis of severe
pancreatitis. Villous atrophy is associated with pancreatic insufficiency, and restored pancre‐
atic enzyme levels are observed after introduction of a gluten-free diet.
By contrast, the relationship between autoimmune pancreatitis and celiac disease has not been
demonstrated, since there is only so far a case report of this association [42].
3.9.2. Inflammatory bowel disease
Pancreatitis has been associated with inflammatory bowel disease, either secondary to the use
of drugs that may potentially cause this disorder or by other mechanisms as duodenal Crohn
´s disease leading to pancreatic flow obstruction, or as a result of the granulomatous disease or
the autoimmune process directly involving the pancreas [43].
3.10. Idiopathic pancreatitis
This  condition is  defined as  pancreatitis  with  unknown etiology established after  initial
laboratory  and imaging studies.  In  some patients  the  cause  may be  found after  further
investigations,  but  in  others  no definitive etiology is  detected.  These patients  should be
evaluated at centers of excellence focusing on pancreatic diseases. It is recommended to complete
a comprehensive study, since biliary sludge/microlithiasis may be detected in up to 75% of
patients with recurrent AP initially labeled as unknown origin, and it has been estimated that
up to 15% of patients with benign or malignant tumors may present as apparent idiopathic
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pancreatitis. Additionally, the role of genetic testing in idiopathic pancreatitis has yet to be
determined, but the study of genetic abnormalities is being increasingly recognized [16,44].
4. Conclusions
Pancreatitis is a common digestive disorder with a broad spectrum of etiologies. Although
most cases are secondary to biliary stones/sludge or alcohol abuse, other potential causes
should be considered once the two most common etiologies have been excluded. One of the
primary goals in the diagnostic process of the pancreatitis should be to reduce the rate of
idiopathic pancreatitis, because the identification of the cause of the disease may help to
prevent subsequent relapses when the etiological factor is eliminated.
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